Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66
In Brief: New Presidents Take Office At ONS, ONCC, ARS; Baird Wins Awards; New VP In Houston
Senate Finance Reports A Reform Bill On Deadline
Pryor Bill Embodies Drug Company Fears
House Bill Gives NCI $48 Mil. Less Than Clinton Requested
House Appropriations by Institute
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says
